Introduction {#ss0}
============

Increasing reports of opportunistic infection by nontuberculous mycobacteria (NTM) in immunocompromised patients such as AIDS patients and elderly people are a matter of serious concern to public health ([@b2]; [@b3]; [@b1]). The routine diagnosis of mycobacteriosis relies primarily on the detection of acid-fast-stained bacilli in the samples by microscopic observation, and the infecting mycobacterial species can be identified with conventional tests including observation of colony morphology and pigmentation, growth rate, and biochemical characteristics ([@b4]; [@b5]). Disadvantages of this approach include the time taken to provide clinically relevant information. The clinician must initiate therapy for *Mycobacterium tuberculosis* against NTM infection several weeks before species identification ([@b3]), which may increase health care costs, and may reduce the social activity of the patients. Therefore rapid detection and identification of the species level of mycobacteria is required, both to decide whether measures are needed to prevent the spread of the disease and for adequate therapy ([@b6]).

The mycobacterium species often implicated in NTM infection are *Mycobacterium avium--Mycobacterium intracellulare* complex (MAC), *Mycobacterium kansasii*, *Mycobacterium chelonae*, *Mycobacterium abscessus*, and *Mycobacterium xenopi* ([@b7]; [@b5]; [@b1]). *Mycobacterium gordonae, Mycobacterium gastri*, or most of the rapidly growing species are rarely pathogenic, but are often encountered as contaminant in clinical samples. Therefore, the discrimination of these species from pathogenic ones is an important diagnostic issue ([@b1]).

Several studies have been conducted to develop rapid methods based on molecular technique for identifying mycobacterial species in recent years. The DNA sequences reported for such usage are those of 16S rRNA gene ([@b9]; [@b8]; [@b10]), *recA* ([@b11]), *rpoB* ([@b12]), *gyrB* ([@b13]), *hsp65* ([@b15]; [@b14]), or 16S--23S internal transcribed spacer (ITS) ([@b16]; [@b17]). The 16S rRNA gene and ITS-based methods are currently widely accepted as rapid and accurate for identifying mycobacteria ([@b15]; [@b16]; [@b18]; [@b19]). However, some species have the same sequence or a very high similarity ([@b12]; [@b13]). This fact indicates the need to develop more reliable and user-friendly molecule-based diagnostic tools.

Recently, [@b20] have reported a novel nucleic acid amplification method, termed loop-mediated isothermal amplification (LAMP), that amplifies DNA with high specificity, efficacy, and rapidity under isothermal conditions. The LAMP reaction requires a *Bst* DNA polymerase with strand displacement activity and a set of four specially designed primers that recognize six distinct sequences on the target DNA, the specificity of which should be extremely high. The amplification products are stem-loop DNA structures with several inverted repeats of the target. The advantage of the LAMP method is that the reaction is performed under isothermal conditions of between 60 and 65°C. As a result, it requires only simple and cost-effective reaction equipment. The LAMP method has emerged as a powerful tool to facilitate genetic testing for various infectious diseases ([@b21]; [@b22]; [@b26]; [@b24]; [@b25]; [@b23]).

The purpose of our work is to identify a species-specific region of *Mycobacterium* sp., and to develop a LAMP assay that can differentiate clinically relevant species.

Materials and methods {#ss1}
=====================

Bacterial strains and preparation of genomic DNA {#ss2}
------------------------------------------------

The bacteria used in this study comprised 27 strains and 49 clinical isolates as shown in [Table 1](#t1){ref-type="table"}. All strains except for *Mycobacterium leprae* were cultured on 1% Ogawa medium (Nissui, Tokyo, Japan) at 37°C. *Mycobacterium leprae* was prepared from infected nude mouse food pad ([@b27]). Genomic DNA was extracted from mycobacterial strains as follows. Mycobacterial cells were resuspended in 1.8 mL of sterile phosphate-buffered saline (PBS) containing 0.1 mm diameter zirconia/silica beads (BioSpec Products Inc., Bartlesville, OK). The mixture was beaded for 20 s with a Beads Homogenizer Model BC-20 (Central Scientific Commerce, Tokyo, Japan), transferred to a 1.5 mL microcentrifuge tube, and the genomic DNA was purified with proteinase K treatment and phenol/chloroform extraction followed by ethanol precipitation, then suspended in 100 μL distilled water.

###### 

*Mycobacterium* species and strains used in this study and results of the loop-mediated isothermal amplification assay

  Species                            Strains                       Accession number   Primer set   
  ---------------------------------- ----------------------------- ------------------ ------------ ----
  *Mycobacterium abscessus*          JATA 63-01 (ATCC 19977)       AB087684           −            −
  *Mycobacterium africanum*          KK 13-02 (ATCC 25420)         AB087685           −            −
  *Mycobacterium avium*              JATA 51-01 (ATCC 25291)       AB087686           −            −
                                     Clinical isolate 22 strains                                   
  *Mycobacterium bovis*              JATA 12-01 (ATCC 19210)       AB087687           −            −
  *Mycobacterium chelonae*           JATA 62-01 (ATCC 35752)       AB087688           −            −
  *Mycobacterium fortuitum*          JATA 61-01 (ATCC 6841)        AB087689           −            −
  *Mycobacterium gastri*             KK 44-02 (ATCC 15754)         AB087690           −            \+
  *Mycobacterium gordonae*           JATA 33-01 (ATCC 14470)       AB087691           −            −
  *Mycobacterium intracellulare*     JATA 52-01 (ATCC 13950)       AB087692           −            −
                                     Clinical isolate 17 strains                                   
  *Mycobacterium kansasii*           KK 21-01 (ATCC 12478)         AB087693           \+           −
                                     Clinical isolate 10 strains                      \+           −
  *Mycobacterium leprae*             Thai-53                       AB087694           −            −
  *Mycobacterium malmoense*          JATA 47-01 (ATCC 29571)       AB087695           −            −
  *Mycobacterium marinum*            JATA 22-01 (ATCC 927)         AB087696           −            −
  *Mycobacterium microti*            KK 14-01 (ATCC 19422)         AB087697           −            −
  *Mycobacterium nonchromogenicum*   JATA 45-01 (ATCC 19530)       AB087698           −            −
  *Mycobacterium parafortuitum*      ATCC 25807                    AB087699           −            −
  *Mycobacterium phlei*              ATCC 19249                    AB087700           −            −
  *Mycobacterium scrofulaceum*       JATA 31-01 (ATCC 19981)       AB087701           −            −
  *Mycobacterium simiae*             KK 23-08 (ATCC 25275)         AB087702           −            −
  *Mycobacterium smegmatis*          JATA 64-01                    AB087703           −            −
  *Mycobacterium szulgai*            JATA 32-01                    AB087704           −            −
  *Mycobacterium terrae*             KK 46-01 (ATCC 15755)         AB087705           −            −
  *Mycobacterium triviale*           KK 50-02 (ATCC 23292)         AB087706           −            −
  *Mycobacterium tuberculosis*       JATA 11-01 (H37Rv)            AB087707           −            −
  *Mycobacterium ulcerans*           KK 43-01                      AB087708           −            −
  *Mycobacterium vaccae*             KK 66-01                      AB087709           −            −
  *Mycobacterium xenopi*             KK 42-01 (ATCC 19250)         AB087710           −            −

All strains were kindly donated by Dr Kashiwabara, NIID.

Clinical isolates were identified by Amplicore *Mycobacterium* kit (Roche Pharma, Basel, Switzerland) or conventional biochemical test ([@b28]).

Amplification of the region within *dnaA* gene {#ss3}
----------------------------------------------

Highly polymorphic regions flanked by conserved regions were identified by aligning the *Mycobacterium* spp. *dnaA* sequences, which were available in GenBank at the time this study was initiated. These regions were used to design a pair of degenerate primers, U1F 5′-GTS CAR AAC GAR ATC GAR CG-3′ and U1R 5′-CCB GAY TCR CCC CAG ATG AA-3′. A schematic representation of the primer design is shown in [Fig. 1a](#f1){ref-type="fig"}. PCR was performed in a TAKARA Thermal Cycler MP (TAKARA Biomedical, Otsu, Japan) with a reaction mixture consisting of 1 μL of genomic DNA, each deoxynucleoside triphosphate at a concentration of 200 μM, each primer at a concentration of 0.4 μM, 1 × PCR buffer with 1.5 mM MgCl~2~ (TAKARA Biomedical), and 1.25 U of ExTaq (TAKARA Biomedical), with 10 μL PCRX Enhancer System solution (Gibco BRL, Rockville, MD) in a total volume of 50 μL. The PCR thermocycles were 3 min at 94°C, followed by 30 cycles of 94°C for 10 s, 50°C for 20 s, and 72°C for 45 s, with a final extension step at 72°C for 7 min. PCR products were visualized by UV illumination of an ethidium bromide-stained 1.5% agarose gel and cut out to purify with EASYTRAP Ver.2 (TAKARA Biomedical) according to the manufacturer\'s instruction.

![Schematic representation of the DnaA protein and primer design for the amplification of the partial mycobacterial *dnaA* gene. Number indicates the nucleotide position of *Mycobacterium tuberculosis*, GenBank accession number AL021427. (a) The DnaA protein from *M. tuberculosis* contains four domains. Domain 1 is involved in interaction with DnaB. Domain 2 constitutes a flexible loop. DNA unwinding required Domain 3. Domain 4 is sufficient for specific binding to DNA. Primers U1F and U1R were used to generate about 400 bp fragment from *dnaA* of 27 mycobacterial spp. (b) Analysis and comparison region used in this study are indicated by a bar (298--508 bp).](FML_232-fig1){#f1}

DNA sequencing and sequencing analysis {#ss4}
--------------------------------------

The ABI Prism BigDye Terminator v3.1 Cycle Sequencing Kit (PE Biosystems, Foster City, CA) was used for the sequencing of the PCR products. The same primers for amplification were used for sequencing. The sequencing reaction was performed in accordance with the instruction of the manufacturer. Sequencing products were purified with a Centrisep column (Princeton Separations, Adelphia, NJ).

The sequencing output was analyzed by using the DNA Sequence Analyzer computer software (PE Biosystems). The partial *dnaA* sequences were aligned using the Clustal W algorithm ([@b29]) of the software DNASpace ver. 3.5 (Hitachi Software Engineering, Yokohama, Japan), and the alignment was manually corrected. A phylogenetic tree was generated by DNASpace ver. 3.5 (Hitachi Software Engineering) with a total of 1000 bootstraps. Pairwise similarity of the partial *dnaA* sequences was determined by using DNASIS package (Hitachi Software Engineering).

Species-specific LAMP assay for *Mycobacterium kansasii* and *Mycobacterium gastri* {#ss5}
-----------------------------------------------------------------------------------

A set of four primers comprising two inner primers and two outer primers that recognized six distinct regions on the target sequence were designed with PrimerExplorer Ver.3 (Fujitu, Tokyo, Japan). The detailed sequences of the primers are shown in [Fig. 3](#f3){ref-type="fig"}. The two inner primers are called the forward inner primer (FIP) and the backward inner primer (BIP), and each contains two distinct sequences corresponding to the sense and antisense sequences of the target DNA, one for priming in the first stage and the other for self-priming in late stages. FIP contains the sequence complementary F1 (F1c) and F2. BIP contains the complementary B1 (B1c) and B2. The two outer primers consist of F3 and B3.

![Location of oligonucleotide primer sets Kan 32 and Gas 583, used for the loop-mediated isothermal amplification method. For *Mycobacterium kansasii* partial *dnaA* gene (GenBank accession number AB087693) and for *Mycobacterium gastri* partial *dnaA* gene (GenBank accession number AB087690). A right arrow indicates the sense sequence which is used as the primer. A left arrow indicates that a complementary sequence is used as the primer. The unique restriction enzyme recognition sites in the amplified product are shown with a bold bar. (b) List of each primer sequence.](FML_232-fig3){#f3}

The LAMP reaction was carried out in 25 μL of reaction mixture by using the Loopamp DNA amplification kit (Eiken Chemical Co. Ltd., Tochigi, Japan) containing 2.4 μM (each) FIP and BIP, 0.2 μM (each) of the outer primers, F3 and B3, 20 mM Tris-HCl (pH 8.8), 10 mM KCl, 8 mM MgSO~4~, 10 mM (NH~4~)~2~SO~4~, 0.1% Tween 20, 0.8 M betaine, 1.4 mM (each) of dNTP, 8 U of *Bst* DNA polymerase (New England BioLabs, Beverly, MA), and the template DNA. Amplification was undertaken in 0.5 μL microtubes in a heatblock under isothermal conditions of 63°C for 60 min, followed by 80°C for 2 min to terminate the reaction. Positive and negative controls were included in each run, and precautions to prevent cross-contamination were observed. Two microliter aliquots of LAMP products were subjected to electrophoresis on a 4% agarose gel in Tris-borate-EDTA buffer followed by staining with ethidium bromide and were visualized on a UV transilluminator at 302 nm. The specificity of the LAMP-amplified products were further validated by restriction enzyme digestion with *Nae*I and *Hae*II for *M. kansasii* and *M. gastri*, respectively. The diluted genomic DNA was used for determining the sensitivity of the species-specific LAMP assay.

Results {#ss6}
=======

Comparison of partial *dnaA* sequence to identify the *Mycobacterium* species {#ss7}
-----------------------------------------------------------------------------

For the species identification of mycobacterial species, we analyzed some possible variable regions of mycobacterial sequences deposited in the GenBank, and found the 5′ part of the *dnaA* gene as a candidate target for PCR amplification. The PCR products with U1F and U1R, from 27 mycobacterial species, showed the ragged pattern around 400 bp in size (data not shown). Therefore, we determined nucleotide sequences, corresponding to position 228--612 bp of *Mycobacterium tuberculosis*, of all 27 species ([Fig. 1a](#f1){ref-type="fig"}). The alignment of the sequence shows that the region (298--508 bp) in the amplified products had the highest species-specific variability ([Fig. 1b](#f1){ref-type="fig"}). The size of the variable fragment in *dnaA* ranged from 154 bp in *M. triviale* to 232 bp in *M. kansasii*. The variable region exhibits a reasonable number of nucleotide substitution and insertion or deletion sites, which is important for the development of a differential diagnostic tool. The lowest interspecies similarity was 28.2% in *M. leprae* versus *M. vaccae*. The similarity between *M. avium* and *M. intracellulare* was 78.3% and that between *M. marinum* and *M. ulcerans* was 97.7%. Pathogenic *M. kansasii* were easily differentiated from nonpathogenic *M. gastri* (83.6%). The sequences of *M. tuberculosis*, *M. microti, M. africanum*, and *M. bovis* were found to be identical, except for one nucleotide substitution that occurred in *M. bovis*. When clinical isolates from clinically relevant mycobacterial strains were analyzed, the following minor variation was found among each species: 97.7--100% (*M. avium*) and 96.0--100% (*M. intracellulare*). We did not find any intraspecies variation in 10 clinical isolates and the standard strain of *M. kansasii*. Because other reports using different systems revealed the existence of more than one sequevar ([@b31]; [@b30]), we may need to examine a bigger number of clinical isolates.

The unrooted phylogenetic tree showed that the 27 mycobacterial species were resolved by the variable region in the *dnaA* sequence ([Fig. 2](#f2){ref-type="fig"}). All rapidly growing species, *M. abscessus, M. chelonae, M. fortuitum, M. parafortuitum, M. phlei, M. vaccae*, and *M. smegmatis*, made a cluster that was clearly separated from those of the other species so far examined. On the other hand, *M. kansasii, M. gastri*, *M. avium*, and *M. intracellulare* are clinically relevant species; however, the branch of the former two species was obviously segregated from one of the later two species, which was supported by high bootstrap values. The results indicated that the partial *dnaA* sequence could be useful for the differentiation of NTM ([Fig. 2](#f2){ref-type="fig"}).

![Phylogenetic relationship of 27 *Mycobacterium* species. Unrooted tree based on the *dna*A sequences. The tree was generated from DNASpace (Hitachi Software Engineering) with the Clustal W algorithm. The numbers on the dendrogram indicate the percentages of occurrence in 1000 bootstrapped trees; only values of \>90% are shown.](FML_232-fig2){#f2}

Identification of mycobacteria by *dnaA* sequence-targeted species-specific LAMP assay {#ss8}
--------------------------------------------------------------------------------------

Several sets of primers designed from the *dnaA* sequence were evaluated for their specificity and sensitivity by the LAMP method. One set of primers named Kan-32 for *M. kansasii* and Gas-583 for *M. gastri* was selected ([Fig. 3](#f3){ref-type="fig"}), and by using these primer sets, a successful LAMP product appeared as a ladder of multiple bands ([Fig. 3a](#f3){ref-type="fig"}).

The species specificity and intraspecies stability of each primer set were examined with purified DNA from 27 mycobacterial species and 10 clinical isolates of *M. kansasii*. We subjected each sample to amplification using Kan-32 or Gas-583 primer set. The results obtained by electrophoretic examination are summarized in [Table 1](#t1){ref-type="table"}. Although 200 pg of nontargeted species DNA were not amplified, significant amplification of targeted respective isolates was observed after a 60 min incubation at 63°C. To confirm that the amplification products had corresponding DNA structures, the amplified products were digested with restriction enzymes and the size of the fragments was analyzed by electrophoresis. *Nae*I cuts between F1 and B1c for the *M. kansasii* amplicon; *Hae*II was used for the *M. gastri* amplicons. The sizes of the fragments generated after digestion were in good agreement with sizes predicted theoretically from the expected DNA structure: 100 and 93 bp by *Nae*I digestion, and 123 and 98 bp by *Hae*II digestion ([Fig. 4a](#f4){ref-type="fig"}). Thus, we concluded that each primer set was species specific.

![(a) Four percent agarose gel electrophoresis and restriction enzyme analysis of loop-mediated isothermal amplification (LAMP) products of partial *dnaA* gene of *Mycobacterium kansasii* and *Mycobacterium gastri*. Lanes: M, 100 bp DNA ladder; lanes 1--3, LAMP carried out with *M. kansasii* primer, Kan 32, in the presence of genomic DNA from *M. kansasii* (lanes 1 and 2) and *M. gastri* (lane 3); lane 2, LAMP product from lane 1 after digestion with *Nae* I; lanes 4--6, LAMP carried out with *M. gastri* primer, Gas 583, in the presence of genomic DNA from *M. gastri* (lanes 4 and 5) and *M. kansasii* (lane 6). lane 5, LAMP product from lane 4 after digestion with *Hae* II. (b) Serial dilution of purified *M. kansasii* or *M. gastri* genomic DNA was amplified to determine the sensitivities by LAMP. Lanes: M, 100 bp DNA ladder; lanes 1--5 LAMP carried out with Kan 32 primer set in the presence of genomic DNA of *M. kansasii*, lane 1, 1000 copies; lane 2, 500 copies; lane 3, 100 copies; lane 4, 10 copy; lane 5, distilled water. lanes 6--10 LAMP carried out with gas 583 primer set in the presence of genomic DNA of *M. gastri*, lane 6, 1000 copies; lane 7, 300 copies; lane 8, 100 copies; lanes 9, 10 copy; lane 10, distilled water.](FML_232-fig4){#f4}

We next assessed the sensitivity of the assay. Serially diluted *M. kansasii* or *M. gastri* genomic DNA was used. The results of a typical experiment are shown in [Fig. 4b](#f4){ref-type="fig"}. Amplified DNA was readily visible when 500 copies of genomic DNA were present in a 60 min incubation assay. The detection limit did not change with a longer incubation period (data not shown).

Discussion and conclusions {#ss9}
==========================

For the identification of species, a target gene must be conserved among strains and species. As the DnaA protein is generally conserved among microbial organisms ([@b32]), this coding region could be used for the target analysis. Four functional domains of the DnaA protein have been defined ([@b33]). Domain 1 is involved in oligomerization and interaction with DnaB, Domain 2 constitutes a flexible loop, Domain 3 has ATPase function, and Domain 4 is sufficient for specific binding to DNA. The variable region that we identified in the *dnaA* sequence was equivalent to the Domain 2 coding nucleotide sequence ([Fig. 1](#f1){ref-type="fig"}). This domain is the least conserved region in the *dna A* gene with respect to sequence and length among *M. smegmatis, M. tuberculosis*, and *M. leprae* ([@b34]). However, comparative studies of this region using 27 mycobacteria have not been reported and, as far as we know, this is the first report indicating the usefulness of the *dnaA* Domain 2 sequence as a differential diagnostic tool.

An accurate and rapid bacterial identification greatly contributes to this field of medication. Several methods based on molecular biological techniques have been reported. The sequences that have been reported include *hsp65*, 16S rRNA gene, and ITS ([@b15]; [@b16]; [@b36]; [@b35]; [@b17]; [@b14]). Each gene has several advantages and disadvantages. An excessive degree of variability is found in the *hsp65* gene ([@b37]), which may hinder the development of reliable probes. While 16s rRNA gene sequence is identical in *M. kansasii* and *M. gastri* and shows narrow divergenicity within species ([@b38]), ITS sequence can be used to distinguish between *M. kansasii* and *M. gastri* ([@b17]). While *M. kansasii* is a representative pathogenic mycobacteria, *M. gastri* does not induce an apparent disease. The discrimination between these mycobacteria provides useful information to select the appropriate therapy. The percent similarity of ITS between two species was 93% ([@b17]), and that of the *dnaA* variable region was found to be 83.6%. These observations may indicate the usefulness of the *dnaA* gene for discrimination of these species, at least in complement with ITS.

The recent trend in genetic testing is to make systems fully automatic with high-throughput analysis. Although this may be an ideal approach, it requires expensive equipment as well as a well-trained person in diagnostic laboratories. The LAMP method could be conducted under isothermal conditions ranging from 60 to 65°C by a single enzyme. The only equipment needed for LAMP reaction is a regular laboratory water bath or a heat block that furnishes a constant temperature around 63°C. LAMP does not require a thermal cycling step, and an isothermal reaction for a short time (60 min) is enough to amplify the target DNA to a detectable level. As PCR and other molecular biological techniques are conducted in well-equipped laboratories, these methodologies are often impracticable under a field diagnosis.

In this paper, we demonstrated that the *dnaA* region could be an effective new nucleotide region for the diagnosis of NTM infection and that the LAMP method could be applied for a *dnaA* gene-based differential diagnostic tool.
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